Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|March 2, 2005
New science-based endpoints to accelerate oncology drug developmentGary J Kelloff, Caroline C SigmanNature Reviews. Drug Discovery|February 11, 2012
Cancer biomarkers: selecting the right drug for the right patientGary J Kelloff, Caroline C SigmanNature Reviews. Cancer|June 15, 2007
Assessing intraepithelial neoplasia and drug safety in cancer-preventive drug developmentGary J Kelloff, Caroline C SigmanUrologic Oncology|March 10, 2015
Biomarker development in the context of urologic cancersGary J Kelloff, Caroline C Sigman, Howard I ScherJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2006
Imaging and oncologic drug developmentWafik S El-Deiry, Caroline C Sigman, Gary J KelloffReviews in Urology|September 21, 2006
Chemoprevention strategies in the prostate: an overviewGary J Kelloff, Howard R Higley, Michael K Brawer, et al.Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinicFrank L Meyskens, Gregory A Curt, Dean E Brenner, et al.Mutation Research|August 9, 2005
Development of cancer chemopreventive drugs based on mechanistic approachesVernon E Steele, Gary J KelloffAJR. American Journal of Roentgenology|May 22, 2009
Challenges in clinical prostate cancer: role of imagingGary J Kelloff, Peter Choyke, Donald S Coffey, et al.Radiology|November 21, 2007
Regulatory and reimbursement challenges for molecular imagingJohn M Hoffman, Sanjiv S Gambhir, Gary J KelloffPageof 4